Company intelligence / Profile preview
Parabon NanoLabs
Reston, Virginia, United Statesparabon-nanolabs.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is developing oncology therapeutics, synthetic vaccines, and diagnostic tools using DNA nanotechnology. No commercial biomedical products have been launched yet, though multiple therapeutics are in development.
- Therapeutic areas
- OncologyInfectious DiseasesNeurology
- Modalities
- DNA nanostructureDNA vaccineNanopharmaceutical
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Edgewood Chemical Biological CenterUnited States Army Research OfficeNational Science Foundation
Beyond the preview
Go deeper on Parabon NanoLabs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Parabon NanoLabs.